An Open-Label Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)

Clinical trial NCT01592786 · COMPLETED

Trial details

NCT number: NCT01592786
Sponsor: Forest Laboratories
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Autism Spectrum Disorder (ASD)Autism Autistic Disorder Asperger's Disorder Asperger's Pediatric Autism Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)

Start date: 2012-06-01
Primary completion: 2013-07-01
Enrollment: 906

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.